Actively Recruiting
Russian Extreme Hypertriglyceridemia Registry
Led by Russian Cardiology Research and Production Center · Updated on 2026-04-02
500
Participants Needed
6
Research Sites
1045 weeks
Total Duration
On this page
Sponsors
R
Russian Cardiology Research and Production Center
Lead Sponsor
R
Research Centre for Medical Genetics, Russian Federation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The REGGI registry is a prospective, multicenter observational registry in Russia designed to collect data on patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L). The registry aims to describe the clinical, demographic, and molecular-genetic characteristics of patients, as well as current diagnostic approaches and treatment patterns in real-world practice. The collected data may inform future research and support improvements in patient care.
CONDITIONS
Official Title
Russian Extreme Hypertriglyceridemia Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with extreme hypertriglyceridemia (triglyceride levels 6510 mmol/L), confirmed by at least two independent measurements.
- Written informed consent from the patient or legal guardian.
- No age restrictions.
You will not qualify if you...
- Extreme hypertriglyceridemia caused by alcohol abuse, uncontrolled diabetes, or other medical conditions unless confirmed after controlling the condition.
- Lack of informed consent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Astrakhan State Medical University
Astrakhan, Russia
Actively Recruiting
2
Chelyabinsk State Medical Academy
Chelyabinsk, Russia
Actively Recruiting
3
Kaluga City Clinical Hospital No. 5
Kaluga, Russia
Actively Recruiting
4
State Medical University
Kazan', Russia
Actively Recruiting
5
National Medical Research Center of Cardiology Named after Academician E.I. Chazov
Moscow, Russia
Actively Recruiting
6
Research Centre for Medical Genetics
Moscow, Russia
Actively Recruiting
Research Team
M
Marat Ezhov, MD, PhD
CONTACT
U
Uliana Chubykina, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here